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Recent years have witnessed the development of an enormous variety of hydrogel-based systems for
neuroregeneration. Formed from hydrophilic polymers and comprised of up to 90% of water, these three-
dimensional networks are promising tools for brain tissue regeneration. They can assist structural and functional
restoration of damaged tissues by providingmechanical support andnavigating cell fate. Hydrogels also show the
potential for brain injury therapy due to their broadly tunable physical, chemical, and biological properties.
Hydrogel polymers, which have been extensively implemented in recent brain injury repair studies, include
hyaluronic acid, collagen type I, alginate, chitosan, methylcellulose, Matrigel, fibrin, gellan gum, self-
assembling peptides and proteins, poly(ethylene glycol), methacrylates, and methacrylamides. When viewed
as tools for neuroregeneration, hydrogels can be divided into: (1) hydrogels suitable for brain injury therapy,
(2) hydrogels that do not meet basic therapeutic requirements and (3) promising hydrogels which meet the
criteria for further investigations. Our analysis shows that fibrin, collagen I and self-assembling peptide-based
hydrogels display very attractive properties for neuroregeneration.
© 2018 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural
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1. Introduction
The nervous system is essential for performing motor, sensory, and
autonomic functions including somatic injury repair. However, the ner-
vous system as a whole and the central nervous system (CNS) in partic-
ular have limited capacity for regeneration, which makes the effects of
neurotrauma, ischemia, hemorrhage, or neurodegenerative disease
devastating and often irreversible [1]. In part, it is caused by the intrinsic
properties of neural parenchyma (insufficiency of progenitor neural
cells in the adult nervous system and a slow ability of mature neural
cells to regenerate, proliferate, and migrate [2]) and the microenviron-
ment formed as a result of injury. This can lead to destruction of the
blood-brain barrier (BBB), cytotoxicity (due to release of proteases,
free radicals and other compounds from necrotic cells), trophic and ox-
ygen deprivation. In the CNS, such a hostile microenvironment can only
promote partial self-regeneration resulting in the formation of glial
scars and cysts [3–5].
At present, there is no effective clinically applicable treatment for
functional recovery after CNS injury, as new therapeutic strategies for
enhancing endogenous repair mechanisms of the nervous system be-
come ineffective. Mainly, this is due to the short half-life and systemic
effects of injectable growth factors and the poor survival, differentiation,
andmigration of transplanted stem cells. One of themost promising ap-
proaches to address these issues is associated with the use of hydrogels,
the three-dimensional (3D) networks formed by hydrophilic polymers
containing up to 90% (w/w) of water [6]. Hydrogels possess tunable
physical and chemical properties [7–9],which in the context of brain re-
generation, are expected to meet the following requirements:
I. Injectability, shear-thinning and self-healing (thixotropy). The
ability of hydrogel to support both viscous flow under shear
stress (shear-thinning during injection) and time-dependent re-
covery upon relaxation (self-healing after injection at the injury
site) are the major requirements for minimally invasive surgery
[10,11].
II. Biocompatibility, low cytotoxicity and immunogenicity and the
lack of mutagenicity. Hydrogel should not be physically sepa-
rated from the host tissue by an inflammation-induced avascular
glial scar and it should not harm the graft or host cells [12,13].
III. Biodegradability. Ideally, this should be coordinated and fine-
tuned by the growing host tissue and lead to complete disap-
pearance over time [12,13].
IV. Interactivity. The hydrogel-forming polymer should have adhe-
sive molecular sequences capable of promoting graft and host
cell proliferation, migration, and differentiation [12,13].
V. Porosity. The pores of optimal size and interconnectivity will fa-
cilitate spatial cell distribution, migration, extracellular matrix
formation, and nutrient and oxygen exchange [7,12].
VI. Lack of swelling. This is important for preventing tissue compres-
sion and subsequent damage [14].
Hydrogels are of great interest for future clinical applications in
neuroregeneration as they dealwith bothmentioned problems (insuffi-
ciency of progenitor cells and injury-induced microenvironment) [6,7]:
they can serve as local transport systems for the delivery of drugs and
signalingmolecules directly to the injury site, and as scaffolds providing
suitable physical support, substrates for adhesion, optimal nutrient and
oxygen exchange, and protection to host and graft cells, thereby facili-
tating extracellular matrix formation. The main role of hydrogels in
neuroregeneration is to exert control over the host neural tissue and
grafted cell fate by supporting attachment, neurite outgrowth, prolifer-
ation, migration, differentiation, and viability [15].
While hydrogel types can be divided and have been classified based
on a variety of their properties in the literature [9,15–22], our review fo-
cuses on the source-chemical classification and the formation mecha-
nisms, with results provided from both in vitro and in vivo studies
(Fig. 1).
Fig. 1. Schematic representation of different hydrogels and their formation mechanisms.
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2. Natural polymers
2.1. Hyaluronic acid
Hyaluronic acid (HA) is a linear polysaccharide that consists of two
alternating units, β-1,4-D-glucuronic acid and β-1,3-N-acetyl-D-glucos-
amine. It is one of the most basic and physiologically relevant extracel-
lularmatrix components discovered [23,24]. HA is ubiquitous in theCNS
where it is dispersed in the neuropil and forms perineuronal nets
(PNNs) [25]. HA has been extensively studied in terms of
neuroregeneration (reviewed in [10,15,17,19,21,26–31]).
2.1.1. In vitro studies
In 2009, Pan and co-workers tested EDC (1-Ethyl-N,N-
dimethylaminopropyl carbodiimide)-cross-linked HA hydrogels for
supporting rat embryonic NPCs (neural progenitor cells) viability and
differentiation [32]. The group sought to determine the effects of HA
modifications with either an antibody against the Nogo receptor or
poly-L-lysine (PLL). They found that HA supported the viability of NPC
independently onmodification due to its cavernous structure providing
sufficient space and nutrient supply. HA preferentially directed NPC
growth toward neurons but it was non-adhesive for this cell line with-
out themodifications. Similar resultswere found in the study on rat em-
bryonic neural stem cells (NSC) by Ren et al. [33] where HA-PLL did not
support NSC differentiation towards oligodendrocytes. These studies
are in agreement with the 2009 in vitro study on EDC-cross-linked HA
hydrogel, where Wei and co-workers examined primary rat hippocam-
pal neurons for viability and differentiation in unmodified, modified
with Nogo receptor antibody and PLL-matrices[34]. The results con-
firmed that HA alone was unable to stimulate differentiation. In 2009,
Nakaji-Hirabayashi et al. investigated the effects of EDC-cross-linked
HA hydrogel modified with BDNF (brain-derived neurotrophic factor)
with rat fetal NSCs [35]. This study also confirmed comparative insuffi-
ciency of HA to support cell viability.
In 2010, Seidlits et al. produced methacrylate-cross-linked HA
(HAMA) hydrogel to study neural cell growth. [23]. The hydrogel’s
bulk compressive modulus varied depending on its metacrylate (MA)
content, while the softest hydrogel (lowestMA:HA ratio) demonstrated
themost efficientmouse embryonic NSCs differentiation. Similar results
were obtained by Hachet et al. [36], who demonstrated that cell adhe-
sion to HAwasmediated by CD44 and RHAMM (receptor for hyaluronic
acid-mediated motility). However, the authors used non-neural mouse
embryo fibroblast NIH 3T3 and human cervical carcinoma HeLa cell
lines.
In 2009, Wang et al. constructed a delivery system based on
EDC-cross-linked HA, which also embedded BDNF and VEGF (vascular
endothelial growth factor)-loaded PLGA (poly[lactic-co-glycolic acid])
microspheres [37]. Such scaffolds provided stable release of both
BDNF and VEGF but were not capable of supporting survival and prolif-
eration of rat embryonic NSCs.
In 2014, McMurtrey reported on PEG (poly[ethylene glycol])
diacrylate-cross-linked HA hydrogel modified with polycaprolactone
(PCL) nanofibers, PCL nanofibers mixedwith gelatin, and PCLwith lam-
inin coating and their effects on SH-SY5Y human neuroblastoma cells
[38]. The paper also confirmed the poor ability of unmodified HA to
stimulate neurite outgrowth.
Lam et al. developed a set of bis-cysteine containing peptide-cross-
linked HA-based hydrogels with various degrees of stiffness modified
with RGD, YIGSR, IKVAV and RDG adhesive peptides [39]. They revealed
that the 337 Pa (storage modulus) hydrogel was the most optimal for
hiPS-NPCs (human induced pluripotent stem cell-derived neural pro-
genitor cells) in terms of cell spreading and attachment. The authors
confirmed the idea that mechanically the softest hydrogel was similar
to that of native brain tissue. These results were supported by the
study of Tarus et al., whousedPEG-bis(thiol)-cross-linkedHAhydrogels
with and without RGD peptide to study their effects on mouse
hippocampal neural progenitor cells (HNPCs) [40]. These authors
found that neurite density was highest in the softest gel with a storage
modulus of 400 Pa, and that neurites extended deeply into this soft
HA-based hydrogel even in the absence of RGD.
Zhang et al. developed a two-layered system of HAMA hydrogel to
mimic natural brain development [41]. The top layer consisted of hydro-
gel impregnated with astrocytes and the bottom layer contained hiPS-
NPCs encapsulated into HAMA. The system demonstrated significant
NPC migration towards the astrocyte layer. The system induced neuro-
nal differentiation, resulting in the appearance of mature neurons
within 3 weeks. Another HAMA hydrogel study carried out by Wu
et al. demonstrated that stiff hydrogel variant with compressive modu-
lus of 1.41 kPa restricted spontaneous neural differentiation of hiPS-NPC
spheroids, while the soft variant (510 Pa) promoted intense neural dif-
ferentiation and neurite outgrowth [42].
2.1.2. In vivo studies
In 2007 Ma et al. cell-free EDC-cross-linked HA hydrogels modified
with Nogo receptor antibody (NgR-Ab) were implanted into middle
cerebral artery occluded (MCAO) rat model [43]. Authors found that
non-modified HA hydrogel did promote regeneration, but clearly less
efficiently than NgR-Ab-modified group; these results were also
confirmed by the behavioral tests.
Wei et al. studied in vivo compatibility of IKVAV-modified
EDC-cross-linked HA hydrogel [44]: an experimental rat traumatic
brain injury group received the hydrogel implantation into unilateral
cortex lesion site, while the control group was left untreated. HA was
again proved to be highly biocompatible as there were no cavities or
scarring in the treatment group 6 weeks after implantation. HA formed
a highly porous network and merged with the host tissue.
In 2009, Lin et al. carried out a similar experiment to Ma et al., but
without the NgR-Ab modification [45]. The control group was treated
with normal saline. This study revealed HA as an effective glial scar for-
mation inhibitor reducing astrocyte proliferation and migration.
Ju et al. investigated the effects of EDC-cross-linked HA hydrogel
impregnated with mouse embryonic NSCs alone or of a HA-PLGA
composite impregnated with cells and loaded with VEGF and Ang1
(angiopoietin-1) in MCAO murine model [46]. Both hydrogels were
also covalently modified with NgR-Ab. Animals received intracortical
implantation of the hydrogels. The results showed that both HA
hydrogels fused with host tissue and remained stable for 10 weeks
after MCAO. Anti-gliosis and anti-inflammatory effects were observed
with functional improvement for both animal groups.
In 2014, Lam et al. studied in vivo structural features of bis-cysteine
containing peptide-cross-linked HA hydrogel covalently modified with
RGD [14]. One week after photothrombotic cortical stroke, mice were
injected with 100,000 hiPS-NPCs with or without the HA-based hydro-
gel. One week later, immunohistochemical analysis indicated that the
softer HA-based hydrogels with a storage modulus of 300 Pa induced
a lower inflammatory response. The authors suggested a shielding role
of HA against the host immune system. Such a HA-based hydrogel pro-
moted neuronal differentiation of the cells but did not improve cell
viability post-transplantation.
In 2016, Moshayedi et al. performed another in vivo study for the
four distinct bis-cysteine containing peptide-cross-linked HA-based
hydrogels: “HA” hydrogel (plain HA with an insensitive to MMPs [ma-
trix metalloproteinases] cross-linker), “HA Nopt” (non-optimized),
“HAMin”, and “HAMax”with varying concentrations of bioactive pep-
tides (IKVAV, YIGSR, and RGD) [47]. These hydrogels were impregnated
with hiPS-NPCs and injected into the mouse brain one week after a
modeled photothrombotic stroke. Immunohistochemical staining two
to sixweeks after the stroke induction showed no significant differences
between all groups in terms of glial response, as evidenced by GFAP and
Iba1 immunostaining, and iPS-NSCs differentiation. This data suggests
that HA is capable of stimulating neuronal differentiation of hiPS-NPCs
regardless of additives.
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Collectively, the overwhelming evidence proves that HA-based
hydrogels holds great promise for brain injury repair: HA is injectable,
biocompatible, biodegradable, porous, ubiquitously present in the CNS
and it provides the foundation for building sophisticated hydrogel sys-
tems. It does not, however, contain any cues that would account for
the interaction with transplanted cells and host tissue. The ability to
direct differentiation is still arguable and can be predetermined by me-
chanical properties of the hydrogel. Overall comments on HA-based
hydrogels in the brain tissue regeneration are summarized in Supple-
mentary table S1.
2.2. Collagen type I
Collagens are extracellular matrix (ECM) proteins self-assembling
into triple polypeptide helices [8]. Collagen type IV is widely presented
in the adult nervous systemwhere it forms basementmembranes of the
blood-brain barrier (BBB) and neuromuscular junctions [48]. Collagen
IV is also a component of Matrigel (see Subsection 2.6.). Collagen type
I supports axonal growth and guidance in neural development, and in
adults resides in the basal lamina of the subventricular zone [49].
Collagen type I also forms dura mater and leptomeninges and is rou-
tinely obtained from rat tails, porcine and bovine skin [50]. Due to its
role in CNS development this protein is considered to be a good candi-
date for brain tissue regeneration [8,15,17,20,21,29,48,50–52].
2.2.1. In vitro studies
In 2007, Brannvall and co-workers developed a two-component col-
lagen type I-HA (1:1 volumemix) matrix to enhance the differentiation
of mouse embryonic, postnatal, and adult NS/PCs (heterogeneous cell
population of neural stem and progenitor cells) [49]. The collagen net-
work provided stability for HA and altogether presented favorable con-
ditions for neuronal differentiation in postnatal cell culture: the cells
exhibited terminal differentiation with different signaling properties
and established synaptic contacts within the scaffold.
Bozkurt et al. compared a collagen scaffold with a fibrin hydrogel
based system for the ability to support neurite outgrowth in the rat dor-
sal root ganglion (DRG) [53]. Although DRG studies deal with the pe-
ripheral nervous system (PNS), they can provide valuable data for
regeneration of the relevant adult neurons. Thus, the study on DRG by
Blewitt et al. [54] revealed that hydrogels with low collagen concentra-
tions (0.4–1.0 mg/mL) helped to achieve the longest neurite extension.
Hydrogels with higher collagen concentration and thus higher stability
required modifications with adhesive recognition peptides to exhibit
similar properties.
Deister et al. studied the effects of the collagen-HA gel on rat DRG
neurite extension [55]. In contrast with study by Bozkurt et al., this re-
search showed that neither collagen, nor HA concentration had effects
on neurite outgrowth and length, thus requiring modifications.
In 2009, Kofron et al. proceeded to guide neuritis using the surface
patterning of hydrogels with laminin- and chondroitin sulfate proteo-
glycans [56]. By placing the DRG layer between collagen type I gel and
either laminin- or proteoglycan-covered glass, authors confirmed
laminins micropatterning ability to guide DRG neurites on the surface
of collagen. In contrast, proteoglycan patterning did not lead to exten-
sion of DRG neurites.
In 2009, Hiraoka et al. investigated collagen-based hydrogel effects
on rat fetal NSCs and found that ~80% of NSCs died within two days by
the anoikis mechanism [57]. Modification of collagen with laminin-
derived peptides increased cell survival and stimulated maturation. In
contrast, in 2010 Yao et al. reported the ability of collagen-based hydro-
gel to support neurite outgrowth in rat pheochromocytoma cells (PC12)
without modifications; however, the laminin gradient was responsible
for directing neurite growth [58].
In 2011, Lee et al. investigated the abilities of laminin- and
fibronectin-modified collagen to stimulate neuro-induction of rat
BMSCs (bone marrow-derived mesenchymal stem cells) [59]. The
resultant gel induced neural development of BMSCs without the use of
chemical differentiation factors, presumably due to the low stiffness of
the three-dimensional collagen microenvironment mimicking native
brain tissue.
In 2012, Swindle-Reilly studied dissociated chick DRG cells in the
collagen gel modified with laminin [60]. The group revealed that low-
concentrated unmodified collagen hydrogels (0.4 – 1.5 mg/mL) sup-
ported neurite growth more so than the modified variant.
In 2013, Koutsopoulos et al. compared viability and differentiation of
themouse adult NSCs in peptide nanofiber hydrogels, Matrigel, and col-
lagen and reported the inferior properties of collagen in contrast to the
studied gels [61].
2.2.2. In vivo studies
In 2010, Yu et al. implanted MCAO rats with commercially available
3D porous collagen sponges containing rat embryonic NSCs [62]. Al-
though present but not in the form of a hydrogel, collagen was shown
to be neuro-compatible.
Zhong et al. carried out a study in a photothrombotic stroke murine
model [63]. The mice were implanted with mouse embryonic NPCs en-
capsulated in HA-heparin-collagen hydrogel. The scaffold did not swell,
protected graft cells from microglia and macrophages and increased
survival of NPCs in the hostile environment. No effect on cellular differ-
entiation and migration was observed when compared to control cells
with no hydrogel.
Hoban et al. provided evidence for collagen type I as a non-cytotoxic
and self-healing hydrogel in situ. The group injected the striatum of
sham rats with glial cell line-derived neurotrophic factor (GDNF)-over-
expressing rat bone marrow MSCs encapsulated in a collagen hydrogel
cross-linked with 4S-StarPEG (PEG ether tetrasuccinimidyl glutarate)
[64]. The hydrogel prevented micro- and macrogliosis compared to
the medium-injected control group. However, the scaffold poorly sup-
ported MSCs survival and decreased in volume several days post gela-
tion in vitro and in vivo.
Liang et al. developed a set of hydrogels with variable HA:gelatin:
PEG diacrylate ratios and used them to encapsulate C17.2 NSCs
(mouse immortalized NSCs), ReNcells (human immortalized NPCs),
and GRPs (human glial-restricted progenitor cells) [65]. This group
found that an increase in gelatin content extended the gelation time
and that HA promoted survival of all cell lines. In contrast, gelatin pro-
moted survival and proliferation only in ReNcells and C17.2 cells. The
hydrogels suppressed the innate immune response and improved via-
bility of ReNcells injected into the striatum of immunodeficient mice.
Nakaji-Hirabayashi and co-workers studied the collagen hydrogel
with or without laminin-derived peptides with rats in vivo: the group
injected rat fetal NSCs encapsulated by the striatum and confirmed
that collagen acted as a barrier for microglia and that modifications
were required to reduce apoptosis and to promote proliferation of
NSCs [66].
In conclusion, it should be kept in mind that collagen type I/gelatin-
based hydrogels are not entirely physiological as collagen proteins are
poorly represented in brain parenchyma. Collagen type I/gelatin-based
hydrogels are injectable, biodegradable, interactive, non-swelling and
can be modified with laminin to promote cell attraction. Prior to their
use in clinical applications, collagen and gelatin-based hydrogels should
be thoroughly tested for immuno-/allergenicity due to their xenogenic
nature. Overall comments on collagen type I hydrogels in brain tissue
regeneration are summarized in Supplementary table S2.
2.3. Alginate
Alginate is a natural polysaccharide composed of β-D-mannuronic
acid (the “M” residues) and α-L-guluronic acid (the “G” residues), pro-
duced by brown algae and some bacteria [67,68]. The hydrogel is typi-
cally produced via inter- and intrachain cation (typically by Ca2+)
cross-linking [69]. Alginate hydrogels are non-biodegradable in
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mammalian brain as long as they do not produce alginases [68]. For re-
cent reviews see [9,13,15,19,67,70].
2.3.1. In vitro studies
In 2007, Ashton et al. looked if they could increase the rate of degra-
dation for the alginate hydrogel without harming rat NPCs [68]. To do
this, they incorporated alginate lyase-loaded PLGA microspheres into
the hydrogel. The study revealed that the NPC proliferation was posi-
tively influenced by the rate of alginate degradation. Non-degradable
control hydrogel negatively influenced cell morphology and decreased
the ability of NPCs to penetrate through the cross-linked hydrogel.
Degraded alginate products did not induce cell death but at high con-
centrations could restrict the proliferation of NPCs.
In 2009, Purcell et al. studied a set of alginate hydrogel beads with
high “G” residues, high “M” residues, “G/PLL” hydrogel beads (PLL-
coated “G” beads), and “M/PLL” beads (PLL-coated “M” beads) [71].
Each hydrogel bead type was also loaded with NGF (nerve growth fac-
tor), GDNF (glial cell derived neurotrophic factor), or BDNF (brain-de-
rived neurotrophic factor) and evaluated with mouse embryonic NSCs.
While NSCs survived and proliferated on either hydrogel type, high
“G” hydrogel beads were more mechanically stable than the “M” type,
thus providing potentially longer isolation from immunity of the host.
Banerjee et al. investigated the influence of alginate hydrogels with
stiffness (elastic modulus) of 0.18, 1.03, 1.73, and 19.7 kPa on prolifera-
tion and differentiation of rat adult NSCs [72]. The softest hydrogel stim-
ulated proliferation and differentiation of cells greater than the other
types. Eftekharzadeh et al. assessed alginate antioxidant properties
[73] using NT2 cell line (human NPCs) and claimed that alginate had
the ability to protect the cells against H2O2, preventing apoptosis via
inhibiting caspase-3 activation and increasing synthesis of the heat
shock proteins Hsp-70, HO-1 protein (Heme oxygenase-1), γ-GCS
(γ-glutamyl cysteine synthetase), and Nrf2 (Nuclear factor [erythroid-
derived 2]-like-2 factor). Alginate also inhibited amyloid β formation,
thus demonstrating a cytoprotective role in vitro.
In 2011, Frampton et al. developed a safe and fast method for fabri-
cation of alginate constructs [74] and applied it to an alginate-cell sus-
pension with embryonic rat hippocampal neurons, LRM55 rat
astroglioma cells, rat cortical astrocytes, and ratmicroglia cells. Alginate
was functionalized with a mixture of RGD, IKVAV peptides, and laminin
before the experiment. This micromolding fabrication method mini-
mized exposure of the cells to potentially toxic Ca2+ ions, resulting in
accelerated maturation of neural cells and increased synaptic electrical
activity of neurons. However, cell migration in these scaffolds was re-
stricted, possibly due to insufficient alginate porosity, in agreement
with results of Ashton et al. [68].
Matyash et al. investigated behavior of rat and human NSCs on soft
alginate hydrogels cross-linked with sub-stoichiometric concentrations
of Ca2+, Ba2+, and Sr2+ ions, with respect to the varying “G” and “M”
content [75]. Authors provided evidence for the ability of non-
functionalized alginate to support neural adhesion and neurite out-
growth. The group also demonstrated that alginate had antioxidant
neuroprotective properties and that neurons preferred a soft matrix.
Moreover, low alginate viscosity was found to be non-detrimental to
neurite outgrowth while high “G” alginate hydrogel was deemed less
permissive to neurites.
Kuo et al. reported the alginate-γ-PGA (poly[γ-glutamic acid])
hydrogel-based inverted colloidal crystal (ICC) scaffold [76]. The group
also modified the scaffold with a TATVHL peptide to induce cell adhe-
sion. The scaffold was highly porous, non-cytotoxic, and promoted neu-
ronal differentiation of mouse iPS-NPCs better than the control. The
morphology of the scaffold depended on Ca2+ concentration and the
degree of cross-linking, while the TATVHL peptide accelerated neuronal
differentiation of iPS-NPCs.
In 2015, Tseng et al. investigated the physical properties of alginate
hydrogels and its interactions with mouse NSC spheroids [77]. The
group reported a number of limitations , making alginate unsuitable
for use in mouse NSC cultures: the hydrogel was non-self-healing, it
was difficult to inject, fragmenting after each injection, and slow to re-
cover after strain-induced stress. Most of these results contradict with
the results by Bozza et al. [78] (see below).
2.3.2. In vivo studies
Ciofani et al. demonstrated alginate as a suitable matrix for in vivo
delivery systems [69]. Tests were performed in mice, which were im-
planted with Ca2+-cross-linked alginate doped withWFA (Wisteria flo-
ribunda agglutinin), labeling perineuronal areas in rat brain [79]).
Alginate served as a suitable delivery system forming an interface be-
tween the implant and host tissue.
In another delivery study published by Emerich et al., either VEGF-
containing or blank alginate hydrogel was injected into the rat striatum,
followed by treatment with quinolinic acid to mimic the onset of
Huntington’s disease [80]. Alginate provided sustained delivery of
VEGF, thus preventingdevelopment of thedisease however nomorpho-
logical or functional recovery was observed in the control groups, simi-
larly to results produced with MCAO rat model [81]. Collectively,
alginate-VEGF system proved to be suitable for neuroprotection and
neuroregeneration.
Bozza et al. studied survival and differentiation of mouse ESCs (em-
bryonic stem cells) and embryonic NSCs in blank alginate, or modified
with laminin, RGD peptide and HA beads [78]. The survival of ESCs
was satisfactory in every type of hydrogel, however 1% alginate
hydrogels supported the highest cell viability and rates of differentia-
tion. Moreover, ESCs cultured in alginate-HA beads formed rosettes
and showed robust neurite growth. Similar results were acquired
using murine NSCs, where alginate was injected into the striatum of
MCAOmice. Alginate was biocompatible and did not induce inflamma-
tion in mice, although functional tests were not carried out. In addition,
alginate showed sufficient in situ polymerization contrary to the study
by Tseng et al. [77].
In conclusion, the disadvantages of alginate-based hydrogels seem
to outweigh the advantages, however they do not fulfill the basic re-
quirements for brain tissue regeneration: self-healing, porosity, and bio-
degradability. This limits the promise of alginates for brain tissue repair.
However, existing in vivo data still attracts research interest to this ma-
terial, especially in terms of further modification with HA or other moi-
eties. Overall comments on alginate hydrogels in brain tissue
regeneration are provided in Supplementary table S3.
2.4. Chitosan
Chitosan is a natural polymer produced by the deacetylation of crus-
tacean chitin N-acetyl-glucosamine residues [15,82]. It is built of ran-
domly bound β-(1-4) D-glucosamine links and N-acetyl-D-
glucosamine. For recent reviews see [9,10,12,15–17,19–21,83].
2.4.1. In vitro studies
In 2007, Crompton et al. studied a PDL (poly-D-lysine) modification
of chitosan/glycerophosphate salt hydrogel and its interactions with
mouse fetal cortical cells [84]. The hydrogel was found to be suitable
for these cells: the modification with PDL promoted survival of the
cells and neurite outgrowth. However, the chitosan hydrogel needed a
long gelling time (30 min), which led to cell sedimentation.
Yu et al. modified with adhesive peptides the thiolated ammonium
persulfate/sodiummetabisulfite-cross-linked methacrylamide chitosan
(MAC) and studied its effects on rat postnatal superior cervical ganglion
neurons [85]: they found that the high porosity of the chitosan hydrogel
was negatively affected by the cross-linking; the intrinsic chitosan cell-
adhesiveness was insufficient and required improvement; lastly, even
methacrylated chitosan was biodegradable by the lysozyme.
In 2009, Cao et al. investigated bioactivity in chitosan-agarose co-gel
[82] and revealed that at pH N 6.5 chitosan chains aggregated when
combined with agarose. However, either co-gel formulation was better
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than unmodified agarose hydrogel for adhesion of chick embryonic cor-
tical neurons. Chitosan also slightly decreased the stiffness in the co-gel
system and chitosan:agarose ratio positively correlated with branching
of neurites.
In 2009, Leipzig et al. investigated the effects of photocross-linked
(2,2-dimethoxy-2-phenylacetophenone photoinitiator) MAC stiffness
on behavior of rat adult NS/PCs [86]. The group defined the Young’s
modulus of 3.5 kPa to be optimal for NS/PCs proliferation. The softest
hydrogel of b 1 kPa supported all three neural tissue lines (neurons, as-
trocytes, and oligodendrocytes), while the stiffest hydrogel of 7.0 kPa
supported oligodendrocyte differentiation. However, the observed ef-
fects could only be true for rat NS/PCs. In 2010 authors reported the
dose-dependent rat NS/PC maturation [87] in response to the MAC
modification with IFN-γ. In another work, the authors used for modifi-
cations the RGD peptide [88].
In 2011, Zhang et al. modified chitosan via PEGcross-linking
[89]. The modification improved self-healing and resistance to
degradation with lysozyme, however the hydrogel could be hy-
drolyzed by the protease papain. In 2015, a similar study was car-
ried out by Tseng et al. [77].
Kuo et al. developed a chitosan-gelatin hydrogel-based ICC scaffold
for rat BMSCs [90]. The group also modified the scaffold with laminin-
derived peptides to induce neuronal differentiation of BMSCs. Obtained
chitosan-based scaffolds were as a result highly porous. BMSCs adhered
to the scaffold, yet chitosan-gelatin hydrogel supported insufficient
neuronal differentiation without modification with peptides. An in-
crease in chitosan content increased cationic cytotoxicity.
In 2016,Wei et al. developed a CEC-l-OSA hydrogel (N-carboxyethyl
chitosan cross-linked by oxidized sodium alginate) and investigated its
physical behavior and interactions with rat fetal NSCs [91]. Briefly, the
hydrogel was self-healing under physiological conditions, stable, and
exhibited cytocompatibility. NSCs proliferated slower in 3D culture
when compared to 2D, but exhibited neuronal differentiation in 3D.
On the other hand, in 2D culture, cells tended to differentiate into
astroglial phenotype.
2.4.2. In vivo studies
Tseng et al., exposed zebrafish embryos to ethanol and subsequently
injected them either with PBS (phosphate-buffered saline), chitosan-
based hydrogel alone, chitosan gel with dispersed NSCs, chitosan with
neurospheres, or cell suspension with no gel [77]. The neuroprotective
effects were assessed through specific movements, spontaneous con-
tractions, and hatching of the embryos. Animals that received
chitosan-neurosphere system injection showed improved functional
recovery.
In conclusion, chitosan- and chitosan/agarose-basedhydrogels show
promising physical properties in terms of shear-thinning and self-
healing but seem to possess poor neuro-interactive cues, i.e. they poorly
stimulate the neurite outgrowth. However, this can be improved by
modifying the mechanical properties of hydrogel and by coupling it
with IFN-γ or RGD (poly)peptides. Chitosan biodegradability definitely
requires further investigation. Overall comments on chitosan- and
agarose-based hydrogels in brain tissue regeneration are summarized
in Supplementary table S4.
2.5. Methylcellulose
Methylcellulose is a compound derived from cellulose polysaccha-
ride via substitution of hydroxyl groups with methoxide groups
[15,17]. While cellulose is a solid material, methylcellulose exhibits
low viscosity as a fluid at room temperature and gels at 37 °C [15]. In
most recent studies, methylcellulose was used in a co-gel with HA
(HAMC). This is reflected in this review. For recent reviews see
[10,15,17–19].
2.5.1. In vitro studies
In 2009, Wang et al. investigated HAMC hydrogel as a drug delivery
system [92]. The group provided evidence that methylcellulose can in-
crease solubility of hydrophobic and other poorly soluble drugs within
the hydrogel. The study suggested that HAMC hydrogels could be
tuned in order to deliver various drugs and to modulate drug release
profiles.
Another drug-delivery approach was proposed by Baumann et al.
[93]. They developed a series of HAMC blends loaded with PLGA parti-
cles. The hydrogel was injectable and self-healing but was swelling
over time. This could be ameliorated at higher concentration of methyl-
cellulose and use of lower concentration of HA.
In 2010, Hsieh et al. produced a composite of HAMC hydrogel and
electrospun fibers based on of either collagen or poly(ε-caprolactone-
co-D,L-lactide) [94]. The group investigated its effects on rat adult NS/
PCs in vitro and in ‘simulated in vivo’ conditions. HAMC hydrogel with
cells was injected through a needle into the 96-well culture plates.
The hydrogel prevented cell sedimentation and aggregation and sup-
ported NS/PCs viability, but it did not promote cell differentiation unless
present in a composite with poly(ε-caprolactone-co-D,L-lactide) fibers.
In 2012, Stanwick et al. performed a drug delivery study on HAMC
with PLGA nanoparticles loaded with NT-3 (neurotrophin-3) [95].
Tam et al. investigated HAMC as a vehicle to deliver adhesive peptides
and rPDGF-A (recombinant platelet derived growth factor subunit
A) bound tomethylcellulose via maleimide-streptavidin-biotin chemis-
try [96]. The studies provided substantial evidence that HAMC can be an
important part of injectable drug delivery systems.
2.5.2. In vivo studies
In 2010, Baumann et al. performed intrathecal delivery of HAMC hy-
drogel with incorporated non-drug-containing blank PLGA nanoparti-
cles in rats [97]. This work provided further evidence on HAMC being
a perspective clinical CNS drug delivery platform. Thus, it was found
that nanoparticles increased the hydrogel stiffness. Both blank and
modified with nanoparticles HAMC acted like aCSF (artificial cerebro-
spinal fluid) in terms of macro- and micro-gliosis.
In a brain regeneration study by Wang et al., HAMC-borne erythro-
poietin was delivered epicortically in stroke-induced mice [98]. The
study pointed at insufficiency of unmodified HAMC hydrogel in stimu-
lating neuroregeneration as it induced host cell proliferation and re-
duced host cell apoptosis only in the erythropoietin-modified form.
Untreated animals showed no significant differences from animals
treated with blank HAMC. HAMC alone reduced the presence of
microglial marker CD68 and astroglial marker GFAP. The same group
of authors also utilized EGF- (epidermal growth factor) or PEG-EGF for
modification of HAMC [99]. In 2013, this team published another
study on sequential epicortical delivery of EGF-PEG and erythropoietin
in this model [100]. EGF-PEGwas encapsulated into PLGA nanoparticles
and erythropoietin was encapsulated into poly(sebaric acid)-coated
PLGA nanoparticles. Such sequential delivery demonstrated promising
results for anti-apoptotic protection, proliferation, and differentiation
of host NS/PCs. Blank HAMC again showed anti-inflammatory and
anti-gliosis effects.
In 2012 Austin et al. subjected rats to spinal cord compression and
subsequently injected the compression sites with either HAMC or
aCSF [101]. The study revealed a trend towards axonal preservation
and functional improvement that could be due to lower production of
cytokines and chemokines. The authors attributed the result to the HA
contribution known to play a role in inflammation and tissue repair by
interaction with inflammatory response-associated cells and ECM
proteins.
In another brain injury repair study, Ballios et al. implanted stroke-
injured mice with mouse adult NSCs encapsulated in HAMC [102]. The
cells were evenly distributed throughout the implant and showed no
sedimentation. HAMC system promoted NSCs survival, penetration
into the host brain and functional recovery.
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Pakulska et al. investigated X-methylcellulose, both thermally and
chemically cross-linked, and its effects upon rat intrathecal injection
[103]. The hydrogel was either blank or modified with chondrotinase
ABC or PLGA nanoparticles loadedwith SDF1α (stromal cell derived fac-
tor). Neither formulation of the hydrogel caused neuroinflammation
and astrocytosis and after 8 weeks in vivo there were no remaining hy-
drogel present in situ.
In conclusion, methylcellulose has been extensively studied in two-
component HAMC hydrogel systems that benefit from the pure
HA hydrogels. The methylcellulose-based system does not possess
any significant drawbacks and is promising for brain regeneration:
methylcellulose-based hydrogels are injectable, biocompatible, biode-
gradable, porous, and non-selling. The only drawback is a limit of its
further modification. Overall comments on methylcellulose and HAMC
as candidates for brain tissue regeneration are presented in Supplemen-
tary tables S1 and S5.
2.6. Matrigel
Matrigel is a mixture of extracellular factors extracted from sarco-
mas of Englebreth-Holm-Swarm mice, also referred to as EHS gel. It is
rich in growth factors and extracellular proteins including collagen
type IV and laminin [15,20,104]. This mixture is highly advantageous
for in vitro studies but use in humans is unlikely due to its non-
standardized composition and possible carcinogenicity. For recent re-
views see [15,20,22,26,105].
2.6.1. In vitro studies
In 2007, Ju et al. investigated the effects of salmon fibrin gel on
mouse embryonic spinal and cortical and rat embryonic cortical neu-
rons. Matrigel cultures served as a control [106]. The study revealed in-
ferior activity of Matrigel and human and bovine fibrin samples for
neurite growth when compared to salmon fibrin.
In 2008, Ma et al. published a study on human embryonic stem cell
(hESC) neural differentiation on 2D surfaces coated with PDL, PDL/lam-
inin, PDL/fibronectin, collagen type I, or Matrigel [107]. Neural differen-
tiation and neurite growth were more intensive on laminin-rich
substrates including Matrigel.
Thonhoff et al. investigated viability and differentiation of human
fetal NSCs (hNSCs) on Matrigel and ‘PuraMatrix’ – a 16-mer consisting
of four RADA peptides, also known as RADA16-I [108]. Matrigel stimu-
lated astroglial differentiation of hNSCs, possibly due to its toxic effects
on neurons. Surprisingly, Matrigel decreased cell viability at a concen-
tration of 10%, but had no effect at 50%. The authors speculated that
astroglial expansion was induced by neuronal death at the initial
phase followed by the proliferation of astrocytes stimulated by growth
factors in the increasing concentration of Matrigel. RADA16-I was
clearly superior to Matrigel.
In 2010, Uemura et al. investigated effects of growth factor-reduced
Matrigel on the survival and differentiation of mouse ES-NPCs (embry-
onic stem cell-derived neural progenitor cells) [109]. Other matrices
tested included collagen type IV, ornithine/laminin, and RADA16-I. In
that study, Matrigel supported the viability, migration, and maturation
of NPCs much more efficiently.
In 2013, Koutsopoulos et al. investigated the viability and differenti-
ation ofmouse adult NSCs in peptide nanofiber hydrogels, Matrigel, and
collagen [61]. Matrigel supported poor survival of NSCs, but still per-
formed better than collagen type I hydrogel and in inducing neuronal
differentiation. However, two weeks later, the peptide nanofiber
hydrogels showed better cell survival.
In studies of PNS, Dewitt et al. reported the Collagen I-Matrigel com-
posite scaffold for maturation of rat primary Schwann cells [110].
Matrigel increased the elastic modulus of the scaffold by more than
1.5-fold A 2016 study by Sun et al. investigated the effects of Matrigel
onmouse postnatal spiral ganglion neurons [111] and foundpositive ef-
fect of Matrigel on cell viability and the maturation of neurons.
2.6.2. In vivo studies
The Uemura group [109] used a murine model for intastriatal injec-
tion of ES-NPCs (embryonic stem cell-derived neural progenitor cells)-
rich Matrigel into one hemisphere and ES-NPCs-rich differentiation
medium into contralateral striatum. The results showed that Matrigel
had an anti-inflammatory effect, promotedNPCsmaturation in dopami-
nergic neurons and host cell proliferation.
In 2010, Jin et al. injected MCAO rats with human NS/PCs encapsu-
lated in and cultured within Matrigel [112], which stimulated matura-
tion of the cells and promoted structural and functional recovery.
However when cells were implanted without Matrigel, or Matrigel
was injected without cells, authors observed negative results.
Before it can be translated into a clinical setting Matrigel has to
be proven not to be carcinogenic. Overall comments on Matrigel
as candidate for brain tissue regeneration are presented in Supple-
mentary table S6.
2.7. Fibrin
Fibrin is a natural enzymatically degradable protein involved in
blood and lymph clotting following injury [15], produced by partial
lysis of fibrinogen by thrombin [21]. As long as it is obtained from the
autologous blood donor, it is highly biocompatible [15,113]. However,
either fibrin itself or increased plasmin activity can induce neuroinflam-
mation [114,115]. For the past decade it has been extensively studied in
terms of SCI and PNS repair [15–17,21].
2.7.1. In vitro studies
In a fibrin-assisted PNS regeneration study [116], fibrinwas found to
be a suitable NGF delivery system, demonstrating the release in depen-
dence of the gel stiffness. In another study authors demonstrated the
advantage of fibrin modification with NGF-binding peptide in order to
enhance the neurite extension in chick embryonic DRG cells [117].
In an SCI study by Willerth et al., murine ES-NPCs were cultured in
fibrin scaffolds in the presence of several growth factors: Shh (sonic
hedgehog), NT-3, bFGF (basic fibroblast growth factor), PDGF (plate-
let-derived growth factor), and CNTF (ciliary neurotrophic factor)
[118]. The ‘cocktails’ containingminimal amounts of growth factors pro-
moted neuronal and oligodendrocytal differentiation in cells and in
their absence differentiated predominantly towards an astroglial
phenotype.
Sarig-Nadir et al. investigated effects of fibrin and collagen composi-
tion on chick embryonic DRG cells [119]: modification of fibrinogen re-
duced neurite length proportionally to PEG content. The neurites
exhibited an abnormal morphology in PEGylated collagen: they did
not branch, compared to the fibrin gels.
Mooney et al. clearly show that fibrin did not induce apoptosis and
promoted neuronal differentiation and maturation of rat fetal NSCs
[120]: all fibrin matrices with varying stiffness supported an increase
in cholinergic and dopaminergic neurons and inhibited glial differentia-
tion. Interestingly, increases in stiffness promoted growth of dopami-
nergic neurons and glial cells. The stiffness was controlled by varying
the ratios between the fibrinogen and/or thrombin.
In 2011, Man et al. studied mouse neonatal DRG behavior in fibrin
[121]. Increases in NaCl and/or fibrinogen concentrations resulted in
formation of a stiffer matrix with smaller pores and inhibited neurite
outgrowth. The gel was shown to be susceptible to cellular MMPs.
2.7.2. In vivo studies
In 2009, Itosaka et al. injected hemisected rat spinal cords with
mouse BMSCs encapsulated in fibrin matrix [113]. Authors observed
that fibrin supported survival, migration, and neuronal differentiation
of BMSCs. In another SCI study by Hyatt et al., fibrin was demonstrated
to be a suitable enzyme delivery system [122]: lesioned rat spinal cord
received an injection of chondrotinase ABC-loaded fibrin hydrogel.
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Fibrin provided prolonged activity of chondroitinase ABC and effectively
prevented GAG (glycosaminoglycan) infiltration into the site.
In conclusion, fibrins are injectable, biocompatible, biodegradable,
porous, and non-swelling hydrogels. Fibrin shows one clear advantage
over other types of protein hydrogels for nervous system repair: it can
have complete biocompatibility when used autologously. Precise con-
trol of its mechanical properties enables neuronal differentiation.
These characteristicsmakefibrin an interesting subject for further tissue
engineering studies but so far fibrin hydrogel systems have been poorly
implemented in brain studies (See supplementary table S7).
2.8. Gellan Gum
Gellan gum is a natural linear polysaccharide produced by Pseudo-
monas elodea, based on monomer unit of D-glucose, L-rhamnose, and
D-glucuronic acid [16,123]. In food industry it is also known as a stabi-
lizer and thickening agent E418 [124]. For recent reviews see
[16,123,125].
2.8.1. In vitro studies
In 2007, Smith et al. proposed gellan gum as a tissue engineering
material [124] and found that gellan gum gelled by divalent cations
was injectable. In 2012, Silva et al. investigated Gellan Gum effects on
rat adult NS/PCs [126]. The study revealed the benefit frommodification
of gellan gum with RGD peptide in order to provide interface sites for
cells and enhance neurite extension. In both modified and unmodified
gels, most NS/PCs differentiated into oligodendrocytes. RGD modifica-
tion prevented cells from forming aggregates prone to apoptosis. The
co-culturing NS/PCs with olfactory glial cells increased proliferation
but not differentiation.
In 2015, Lozano et al. presented a 3Dmammalian brain cortex tissue
model printed with RGD-modified gellan gum [127]. The model
consisted of rat primary cortical neurons arranged in six layers. The
gel supported cell viability, differentiation, and promoted neurite inva-
sion into neighboring layers. Thus, RGD-modified gellan gum protected
the cells during the process of hand-held bioprinting. However, neurons
did not respond well to the unmodified gel. In addition, gellan gum
needed purification from divalent cations to perform injections during
bioprinting. In 2015, Ferris et al. assessed PC12 cell line survival, growth,
and normal function in the RGD-modified gellan gum [128]. The latter
cues were all retarded in the unmodified gellan gum.
In 2017, a study on gellan gum cross-linked with poliamines and its
compatibility with hiPS-NSCs was published by Koivisto et al. [129].
Spermine and spermidine were used as cross-linkers, and higher SPM
or SPD content resulted in the increase of compressive moduli of the
gels from approximately 3.5 kPa (0.40% Spermine) to approximately
22.5 kPa (3.00% Spermidine). Spermine-cross-linked gellan gum dem-
onstrated typical hydrogel behavior (G’NG”). Spermidine caused very
rapid gelation, the result being the formation of nucleating cross-
linking spots, and at the same time supported highest rate of neurite
outgrowth. All hydrogel types were shown to be non-toxic to hiPS-
NSCs.
Collectively, gellan gum is a novel biomaterial in neuroregeneration
studies but so far it has been poorly implemented in vitro and was not
yet studied in in vivo (See Supplementary table S8).
2.9. Self-assemblingpeptide/protein-based hydrogels
The hydrogels made of self-assembling peptides are synthesized
from naturally occurring and reusable amino acids. They are commonly
arranged into di- [130], tri- [131], and tetra-block [104] amphiphilic co-
polymers. They self-assemble in water into 3D structures with hydro-
phobic core and hydrophilic outer surface when exposed to millimolar
concentrations of monovalent cations [15,104]. Self-assembling pep-
tides are reviewed in this subsection along with some protein-based
hydrogels. For recent reviews see [10,15,17,21,132–135].
2.9.1. In vitro studies
In 2007 Fisher et al. genetically engineered two triblock protein
hydrogels: unmodified CRC protein (“R” is for random coil middle
block and “Cs” are for ampholytic leucine zipper flanking domains)
and CRC-RGDS. RGDS adhesive peptide was inserted into the R domain
[131]. They tested the peptides physical behavior and the impact on rat
adult hippocampal NSCs. Both proteins had identical secondary struc-
ture. The proteinsweremore stable inwaterwhen compared to the cul-
turemedium. In vitro studies showedgreater adhesion, distribution, and
proliferation of rat NSCs cultured on RGDS-modified substrate.
In 2008, Nakaji-Hirabayashi et al. a genetically engineered chimeric
protein consisting of a long R-helical polypeptide, keratin-14 (K14)
and globular domain 3 of laminin R3 chain (LG3) incorporated into α-
keratin hydrogels [136]. The hydrogel self-assembled via coiled-coil do-
mains. Pure keratin, keratin/LG3K14, and keratin/K14 hydrogels simi-
larly supported viability of rat fetal NS/PCs. The modification with
LG3K14was shown to significantly improve cell adhesiveness, differen-
tiation, proliferation, and distribution. Few drawbacks of this system in-
cluded the need for dissolving keratins by strong denaturants such as
urea or thiourea and the lack of knowledge on their in vivo degradation.
In 2009, Koutsopoulos et al. studied drug-releasing properties of the
RADA16-I hydrogel loaded with various functional proteins including
lysozyme, soybean trypsin inhibitor, BSA (bovine serum albumin), and
IgG [137]. The results showed that the peptide did not alter secondary
and tertiary structures and the proteins remained functional; the re-
lease kinetics was tunable by changing the peptide nanofiber density.
In 2010, Gelain et al. investigated the release of bFGF, VEGF, and
BDNF from the delivery systems based on RADA16-I peptide, RADA-
DGE (RADA16-I modified with GGDGEA peptide motif), or RADA-PFS
(RADA16-I modified with GGPFSSTKT peptide motif) [138]. The release
characteristics depended on the charge correlations. RADA16-I was
shown to be less negatively charged than RADA-DGE and less positive
than RADA-PFS, while VEGF was negatively charged and bFGF and
BDGF were positively charged. The drastic charge differences in
hydrogel-drug systems resulted in a prolonged and incomplete drug re-
lease. The functional activity of bFGF released from RADA16-I and
RADA-DGE hydrogels was confirmed with the mouse adult NSCs.
Ortinau et al. investigated the effects of RADA16-I hydrogel and its
modification with laminin using human NPCs [139]. The modification
induced cell differentiation and maturation into dopaminergic neurons
and prevented aggregation of the NPCs. RADA16-I with a laminin con-
centration of 0.25% induced the highest dopaminergic maturation of
the neurons.
In 2010, Zhang et al. proposed a modification of RADA16-I with
IKVAV [140]. The group examined three different matrices: pure
RADA16-I, RADA16-IKVAV, and their combination called IKVAVmx
with neonatal mouse NSCs. IKVAVmx hydrogel was found to be the
most beneficial in terms of cell proliferation, distribution, migration,
neuronal lineage differentiation, and maturation.
In a PNS study by Li and Chau, the IKVAV peptide was tested with
three following matrices: RADA16-I termed as (RADA)4, (RADA)3IKVA
V(RADA)3 termed as 3IKVAV3, and (RADA)4-IKVAV termed as 4IKVAV
[141]. Themodification of the original hydrogel did not show significant
effect on its structure. IKVAVmodification enabledmore intense neurite
outgrowth, neural differentiation,maturation, and improved viability of
PC12 cells. The highest viability, proliferation, and maturation were ob-
served with 3IKVAV3 matrix.
In 2010, Taraballi et al. developed RADA16-I matrices modified with
another functional biological motif, PFSSTKT, also known as BMHP1 –
bone marrow homing peptide 1, with or without glycine spacers
[142]. The resultant peptides included RADA16-I-PFSSTKT termed as
0G-BMHP1 (no glycine spacers), RADA16-I-GGPFSSTKT termed as 2G-
BMHP1 (two glycine spacers), and RADA16-I-GGGGPFSSTKT termed
as 4G-BMHP1 (four glycine spacers). The group studied the structure
of these hydrogels and their effects on mouse NSCs. Modifications did
not significantly alter structure of the original RADA16-I matrix, but
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made it more stable, with the exception of the 0G-BMHP1 hydrogel. The
highest cell distribution, adhesion, and survival were observed with the
4G-BMHP1 hydrogel.
In 2011, Cunha et al. compared RADA16-I hydrogels modified with
RGD, BMHP1, and BMHP2 [143]. The viability of mouse adult NSCs
was high in all tested matrices. However, cell proliferation was higher
in the BMHP2- and RGD-modified hydrogel. RADA16-RGD stimulated
the most robust differentiation. These peptide scaffolds could be also
tuned by altering the concentration to meet the needs for appropriate
stiffness.
In 2012, Yla-Outinen et al. characterized the lifespan of human ES-
NPC grown on the top layer, under or encapsulated in RADA16-I in com-
parison to the laminin-coated surface [144]. The study showed that re-
gardless of location in the matrix the RADA16-I cell survival was
sufficiently high. RADA16-I stimulated differentiation and maturation
of the cells; and neurite outgrowth was greater with the RADA16-I hy-
drogel, especially in 0.25% RADA16-I, when compared to the laminin-
coated surface. The matrix was also compatible with glial cells, with
the best results achieved in 0.10% RADA16-I. The neuronal networks
grown from ES-NPCs inside the gel showed spontaneous electrical ac-
tivity. The authors observed no benefits from functionalizing the hydro-
gel with laminin.
In a cultivation protocol by Liedmann et al., human NPCs were cul-
tured on either unmodified RADA16-I or on RADA16-I-laminin [145].
The cells showed improved distribution and neuronal differentiation
on RADA16-I-laminin. In 2013, Koutsopoulos et al. compared the viabil-
ity and differentiation of mouse adult NSCs in RADA16-I, Matrigel and
collagen-based hydrogels. RADA16-I was either blank or modified
with peptides including GG-SKPPGTSS, GG-PFSSTKT, or GG-RGDS (GG
is for glycine-glycine spacer) [61]. All peptide hydrogels showed supe-
rior survival of the cells and the greatest survival was observed for the
GG-SKPPGTSS-modified RADA16-I. Unmodified peptide hydrogel in-
duced weaker neuronal differentiation of cells when compared to the
Matrigel.
In a PNS study by Lampe et al. (2013), hydrogels composed of
elastin-like proteins were tested with chick embryonic DRG cells
[146]. The proteins were also modified with either adhesive RGD or
non-adhesive RDG peptides. The elastic modulus of the resultant
hydrogels could be tuned by varying cross-linking density by tetrakis
(hydroxymethyl)phosphonium chloride. Viability of the cells was not
altered by stiffness and RGD incorporation. On the other hand, neurite
outgrowth was induced by RGD incorporation and was increased in
the softest hydrogels with an elastic modulus of 500 Pa.
2.9.2. In vivo studies
In 2008, Sierpinski et al. published a study on peripheral nerve repair
by human hair-derived keratin hydrogel using tibial nerve transection
model [147]. Though being a PNS study, it provided us with important
cues about keratin-based hydrogels, which are highly porous and can
stimulate the neurite outgrowth and vascularization.
In 2009, Yang et al. developed a library of diblock copolypeptide
hydrogels including combinations of lysine and leucine (KxLy), arginine
and leucine (RxLy), glutamate and leucine (ExLy). Plain poly-lysine (Kx)
was also utilized as a non-gelling control [130]. The peptide solutions
were injected unilaterally into the caudate putamennuclei ofmice. Con-
trols received an injection of sterile saline. Physical behavior of the pro-
teins depended on the composition: K190L10 did not form a gel in vitro
nor in vivo; K170L30-0.5%, K160L40-0.25%, and K160L40-0.5% did not gel
in vivo; K180L20-3%, E180L20-2%, and R180L20-3% poorly gelled in vitro
but consistently gelled in vivo. Diblock copolypeptide hydrogels caused
minimal gliosis, visible inflammation in situ, however no evident toxic-
ity to neuronswas detected. The gels also induced ingrowth of endothe-
lial cells and stimulated vascularization. However, limited ingrowth of
nerve fibers and neuron-supportive astroglia was observed.
Guo et al. injected RADA16-I and sterile saline as a negative control
into the brain injury sites in a rat TBI model [148]. The results were
promising: the cavity injected with self-assembling peptides reduced
significantly in size and integrated with no obvious gaps, showed de-
creased astrogliosis and microgliosis. However, RADA16-I did not pro-
mote neural-lineage cell migration and migration of oligodendrocytes,
in addition the protection from apoptosis was lower when compared
to controls.
In 2013, Cheng et al. tested the IKVAV modification of the hydrogel.
The authors injected rats with either RADA16-I or RADA16-IKVAV after
traumatic brain injury [149]. The animals were divided into five groups
according to the injectate: (1) RADA16-IKVAV with encapsulated rat
NSCs; (2) RADA16-I with encapsulated rat NSCs; (3) plain RADA16-
IKVAV; (4) plain NSCs; (5) sterile saline. Both hydrogels supported sur-
vival and promoted proliferation of the encapsulated cells. Proliferation
was more prominent in the IKVAV-modified hydrogel. Neuronal differ-
entiation, maturation, adhesiveness, distribution, neurite outgrowth
was also enhanced in RADA16-IKVAV. Regeneration was significantly
delayed in the hydrogel-only group.
In 2016, Francis et al. performed neuronal induction of human iPS-
NPCs, encapsulated the cells into RADA16-I microspheres and injected
them into the mouse striata eight days after encapsulation [104]. Pre-
culturing allowed the cells to synthesize the extracellular matrix pro-
teins including collagen and laminin, promoting neurite outgrowth
and enhancing survival of the cells in vivo. Microspheres supported via-
bility of the cells in vivo and provided excellent integrationwith the host
tissue.
Collectively, self-assembling peptide/protein-based constructs rep-
resent the most heterogeneous group of hydrogels. Their drawbacks
are easily adapted by modifications. For example, modifications of the
hydrogels with IKVAV, BMHP1 or RGD peptides increase cell viability
neuronal differentiation and neurite outgrowth. Their mechanical prop-
erties are easy tunable by the polymer concentration adjustment or
cross-linking. In vivodata are also promising for the translation to a clin-
ical setting (see Supplementary table S9).
3. Synthetic polymers
3.1. Poly(ethylene glycol)
Poly(ethylene glycol) (PEG) has been the most extensively studied
synthetic hydrogel. Apart from PEG hydrogels, PEG has beenwidely im-
plemented in modification of other hydrogels [7,15,150,151].
3.1.1. In vitro studies
In 2007, Mahoney et al. encapsulated rat embryonic NPCs into a
photopolymerized PEG-PLA (poly[lactic acid]) hydrogel using Darocur
2959 initiator and modified it with collagen and bFGF-2 [152]. PLA
was introduced into the hydrogel and provided its degradability. It
was found that PEG-PLA hydrogel supported intense cell proliferation
without collagen and it was further increased with incorporated bFGF-
2. In contrast, collagen did not increase cell viability, causing aggrega-
tion of NPCs and inhibiting the effects of bFGF-2.
Hynes et al. modified the PLL hydrogel with either a linear or a
four-arm acrylated PEG photopolymerized using Irgacure 2959
photoinitiator [153]. Linear PEG-modified polymer remained
undegraded after 24-hour exposure to trypsin while four-arm
PEG modifications resulted in a higher stiffness. Incorporated mouse
postnatal NPCs showed minimal degree of apoptosis after the
photopolymerization. Four-arm PEG gel supported viability and pro-
moted mostly neuronal differentiation of the cells by an unknown
mechanism. The same group developed a library of 52 hydrogels com-
posed of linear or four-armPEG and PLLwith varyingmolecularweights
[154]. The hydrogels with four-arm PEG compositions contained a
greater amount of free amines and were enzymatically degradable.
With the mouse postnatal NSCs the high free-amine variants (N 3.0
μmoles/mg) were found to be cytotoxic. Hydrogels enhancing cell mi-
gration had elasticmoduli ranging from3.5 kPa to 5.5 kPa. Higher elastic
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moduli, for example with the “D3b” (70-150 kDa PLL cross-linked with
2 kDa PEG, NH3:OH ratio of 3:1) gel having a stiffness of 20 kPa led to
decreased neuronal differentiation. Neuronal differentiation was more
pronounced with the 70-150 kDa PLL hydrogels than with 150-300
kDa PLL hydrogels.
In a PNS study by Dadsetan et al., an oligo-(polyethylene glycol) fu-
marate was photocross-linked (Irgacure 2959 as photoinitiator) with
[2-(methacryloyloxy)ethyl]-trimethylammonium chloride, which
allowed for the fabrication of a cationic hydrogel [155]. The authors in-
vestigated rat embryonic DRG cells seeded on such hydrogels and found
that it promoted neurite extension.
In 2009, Namba et al. developed a porous PEG-fibrin modified hy-
drogel network [156] and tested it with rat primary embryonic neural
cells. The fibrin network was sequentially cleaved by collagenase but
with no effect on cell viability. Such porous PEG scaffold enabled neurite
outgrowth in contrast to non-porous and fibrin-containing hydrogels,
which inhibited it.
The compatibility of the photocross-linking process with cells is still
debatable. In a study by Mooney et al. (see also Subsection 2.7.) used
photopolymerized PEG-PLA as a negative control for evaluation of
photoencapsulation-induced apoptosis in fetal rat primary neuron
cultures [120]. Darocur 2959 was used as the photoinitiator that
cross-linked PEG via end-capping methacrylate groups. The
photoencapsulation process resulted in massive cell death and increase
of Caspase activity compared to fibrin matrix.
In 2010, Scott et al. developed two-component hydrogels composed
of PEG and collagen type I and investigated their effects on surface-
seeded DRG and PC12 cells [157]. The PEG-collagen conjugate was fab-
ricated by covalent binding of acryl-PEG-N-hydroxysuccinimidyl to the
amino groups of collagen. Next, the conjugate was mixed with PEG
diacrylate in different proportions and cross-linked with Irgacure 2959
photoinitiator. The increase in PEG-collagen ratio reduced hydrogel
stiffness and increased the mesh size, as the collagen terminated the
growing PEG chain. The neurite extension of PC12 and embryonic
chick DRG cells was markedly more improved in the softest 3% PEG
gel with the highest collagen content.
In order to tune biodegradability, Lampe et al. photo-co-polymerized
slowly degrading PEG with quickly-degrading PLA-b-PEG-b-PLA [158]
via grafted methacrylate groups and Irgacure 2959 photoinitiator. The
team investigated the effects of the resulting hydrogel on the encapsu-
lated rat primary embryonic neurons: modification with PLA allowed
for hydrogel degradation, while unmodified PEG induced cell death, ox-
idative stress, and slower proliferation.
The same team investigated the impact of PEG macromere concen-
tration on photo-encapsulated rat embryonic NPCs and found that
astro-glial differentiation and “glial-scar” gene expression increased
with increasing PEG content [159]. Higher PEG content also increased
apoptosis and reduced metabolic activity in cells. PEG with 7.5% (wt)
had stiffness close to that of the native brain and was the only hydrogel
that supported cell proliferation.
In 2011, Marquardt andWillits employed laminin binding to reduce
the stiffness of the PEG hydrogel in order to study the growth of chick
embryonic DRG photo-encapsulated into PEG diacrylate [160]. Laminin
conjugation to acrylate groups blocked the cross-linking and decreased
stiffness of the gel, while the increase in PEG increased the hydrogel
stiffness. DRG cells displayed longer neurites in softer gels and gels
modified with laminin.
In a PNS study, Curley and Moore utilized a two-component hydro-
gel system composed of PEG hydrogel without cells and RADA16-I hy-
drogel with suspension of rat embryonic DRG cells [161]. PEG
hydrogel was photopolymerized via grafted methacrylate groups
using Irgacure 2959 photoinitiator and its external layers were used as
a support for RADA16-I in such ‘2.5D’ model. DRG neurite extension
was observed both in RADA16-I and on the surface of PEG hydrogels,
however neurites did not grow into the PEG layer, which also tended
to detach.
Tamariz et al. used a PEG-Si (a thixotropic hydrogel with dis-
persed silica nanoparticles) hydrogel to create a functional gradient
of recombinant semaphorin 3A to enhance axonal outgrowth from
rat embryonic dopaminergic neurons [162]. In this study, a PEG-Si
drop that contained mouse IgG-Alexa Fluor 488 conjugate was em-
bedded in collagen to simulate interaction with the extracellular
matrix in vitro. PEG-Si provided gradual diffusion of IgG-Alexa
Fluor 488 conjugate into the adjacent collagen matrix. The
Semaphorin 3A-containing system increased axonal growth in a do-
paminergic culture. PEG-Si showed no cytotoxicity for neurons and
biodegraded in a simulated body fluid.
A similar approachwas employed by Lee et al. to develop a thixotro-
pic system comprised of photocross-linked PEG hydrogel with embed-
ded PLGA microparticles loaded with IGF-1 (insulin-like growth factor
1) [163]. Such a systemwas expected to produce a propagating gradient
of the drug for axonal growth direction. In addition, authors modified
the hydrogel surface with the axon-guiding fibronectin and laminin
and tested it with suspension of mouse ES-NPC. The axons reached
the targeted length (5 mm) within 10 days with neuroblasts migrating
along the axons.
3.1.2. In vivo studies
In 2008, Bjugstad et al. implanted a PEG-based hydrogel into primate
striatum and frontal cortex in a green monkey model [164]. The PLA-b-
PEG-b-PLA triblock polymer was photocross-linked via grafted methac-
rylate groups (Irgacure 2959 as photoinitiator) to form a hydrogel. One
hemisphere received a hydrogel injection, the contralateral hemisphere
received no injection butwas exposed to needle damage similar towhat
occurs during the injection procedure (sham-implanted group). One
animal also received a bilateral PEG-GDNF injection. After 4 months,
all hydrogels completely degraded. A softer 13% w/v PEG hydrogel
caused minimal astro- and microglial infiltration similar to that in
sham-treated group, while 20% w/v PEG and GDNF produced only a
slight increase in glial response. Thus, GDNF remained active demon-
strating that PEG was a promising drug delivery system. In 2010, the
same team implanted a similar hydrogel into the rat brain close to
substantia nigra [165]. The hydrogel showed insignificant swelling
in vivo but did not degrade completely over the course of 56 days. All
hydrogels (fast-degrading, slow-degrading, and non-degrading) caused
significantly weaker astrogliosis when compared to the sham group.
Fast-degrading hydrogels caused the weakest microglial response
even when compared to the sham group.
In the in vivo part of the study by Tamariz et al., PEG-Si was injected
into the rat striatum [162]. The contralateral hemisphere received an in-
jection of sterile saline. A significant increase in inflammatory and
astroglial responses was observed after 30 days in the polymer-
injected hemispheres.
In 2011, Lampe et al. injected into the caudal area of the rat brain
near the substantia nigra and the rostral area adjacent to the striatum
with PLA-b-PEG-b-PLA triblock-derived hydrogel with embedded
PLGA microparticles and loaded with GDNF and BDNF [166]. Both hy-
drogel systems provoked weaker inflammatory responses than with
control BSA injection and initial swelling was minimal. BDNF-bearing
hydrogel induced astrocytic invasion.
In conclusion, PEG-based hydrogels possess poor physical properties
and are intrinsically non-interactive until they are modified. Collagen
and laminin modifications of PEG can reduce the hydrogel stiffness,
while polylactide modification helps its biodegradability. The majority
of methods of cell encapsulation into PEG hydrogel are based on
photo/chemical cross-linking, potentially affecting their viability. In
vivo studies revealed inflammatory reactions following PEG hydrogel
implantation. Thus, PEGhydrogel systems seem to be inferior compared
to the natural hydrogels, for brain tissue regeneration. Overall com-
ments on PEG-based hydrogels properties for brain tissue regeneration
are provided in Supplementary table S10.
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3.2. Methacrylates and methacrylamides
Methacrylate is extensively used for fabrication of PEG-based
hydrogels. We focus here on mono-component methacrylate- (MA-)
and methacrylamide- (MAA-) based hydrogels, mostly used in in vivo
studies of SCI repair [12,15–17,19,151].
3.2.1. In vitro studies
In 2008, Woerly et al. modified a pHPMA (poly[N-(2-hydroxypro-
pyl) methacrylamide]) hydrogel with sialic acid, which can be recog-
nized by growth factor receptors [167]. The acrylated 3′-sialyllactose
was copolymerized with HPMA monomers via free radical cross-
linking co-polymerization. Sialyllactosyl did not significantly influence
porosity of the hydrogel, but did reduce its swelling.
In a PNS study by Jhaveri et al., pHEMA (poly[2-hydroxyethyl meth-
acrylate]) was tested as a neurotrophin delivery system in rat postnatal
DRG culture [168]. In order to control the NGF release rate, the hydrogel
was modified in two variants, namely pHEMA-Lys and pHEMA-NaCl:
covalent binding of lysine provided the hydrogel with positive charge
and reduced NGF release. The preparation of the hydrogel in 0.6 M
NaCl solution enlarged the pores and induced the NGF release. How-
ever, the hydrogels remained poorly porous and extremely stiff. Elastic
moduli were 93 kPa for pHEMA-NaCl hydrogel and 350 kPa for pHEMA-
Lys hydrogel, which was softer than the unmodified variant. Signifi-
cantly longer neurites were grown from DRG explants when NGF was
released from pHEMA-Lys hydrogel; this was likely due to longer expo-
sure to the drug.
In 2010, Kubinova et al. published a study on human fetal NSC be-
havior in IKVAV-peptide-modified p(HEMA-AEMA) superporous hy-
drogel [169]. The authors revealed the need for grafting adhesive
moiety to the hydrogel to achieve acceptable cell distribution, differen-
tiation, and maturation.
In 2014, Pertici et al. used a PLA-b-pHEMA hydrogel in a SCI model
[170]. The in vitro part of the study confirmed that the hydrogel was de-
gradable and porous. Embryonic rat spinal motor neurons showed ro-
bust neurite growth proving lack of cytotoxicity for the hydrogel.
3.2.2. In vivo studies
Woerly et al. injected Parkinson’s disease model rat striatum with
cell-free sialic acid-functionalized pHPMA hydrogel [167]. The
hydrogels remained stable after 4 months of observation, integrated
well with host parenchyma and induced only small inflammatory re-
sponse with no glial scars formation. The hydrogels also stimulated vas-
cularization, host cell migration and differentiation towards neurons
and stimulated growth of dopaminergic nerve fibers.
In 2008, Hejcl et al. implanted rats with pHEMA hydrogel to the site
of spinal cord transection [171]. The hydrogel integrated well with the
tissue, ameliorated the glial response and stimulated axonal in- and
trans-growth. In another study, the same group implanted the
balloon-induced compression lesion with either blank pHPMA-RGD or
the hydrogel populated with rat MSCs during shaking [172]. In such
chronic spinal cord injury model, the hydrogel stimulated axonal
growth, neuronal migration, but did not prevent formation of astro-
glial scars. However, marked functional improvement was noted in an-
imals treated with the hydrogel-MSC system.
In 2013, Kubinova et al. utilized highly porous poly-[2-hydroxyethyl
methacrylate-co-2-aminoethyl methacrylate] (p[HEMA-AEMA])
hydrogels and their modifications with SIKVAV peptide to implant
into hemi- or trans-sectioned spinal cord of rats [173]. From the types
of hydrogel tested, the variant with moderate porosity (68%) and mod-
erate stiffness (27 kPa) showed the best axonal ingrowth stimulation
and gave no rise in cavity formation.
Another SCI study was published by Pertici et al. [174]. This group
injected the site of spinal cord injury with blank pHPMA hydrogel. The
hydrogel successfully bridged the defective spinal cord leading to better
functionalitywhen compared to the untreated group. The hydrogel pro-
moted axonal growth but led to an increase in macrophage-monocyte
infiltration. However, the process of axonal regeneration can also be
guided bymicroglia. The authors speculated that such inflammatory in-
filtration was due to the cell retention within the gel.
Li et al. described the effects of pHEMA behavior in rat microscale
spinal cord lesion model [175]. They confirmed that pHEMA attenuated
astro-glial response and production of neuro-inhibiting neurocan
(CSPG) but at the same time recruited microglia cells. The scaffold was
pushed out from the lesion site, which indicated it as being unsuitable
for micro lesion treatment.
In the in vivo part of the SCI study by Pertici et al., the PLA-b-pHEMA
hydrogel was implanted into rat spinal cord at hemitransection injury
site [170]. The results indicated that the hydrogel induced axonal regen-
eration and prevented glial scar formation, however, microglia and
macrophage infiltration occurred eight weeks post-surgery.
In conclusion, the main drawbacks for MA- and MAA-based
hydrogels are non-biodegradability and high stiffness independent of
existing modifications. These disadvantages make them generally un-
suitable for implantation into the brain that has been mirrored in the
in vivo studies. However, these materials might be promising for spinal
cord injury repair. Overall comments onMA- andMAA-based hydrogels
in brain tissue regeneration are given in Supplementary table S11.
4. Summary and outlook
The role of hydrogels in nervous system regeneration in general and
in spinal cord regeneration in particular has been widely reviewed
[19–22,28,70,105]. However, the structural and chemical properties of
usable hydrogels have not been sufficiently studied [133,176,177]. In
this review, we performed analysis of the recent literature data related
to the applicability of hydrogels for brain tissue regeneration with the
focus on essential parameters of each hydrogel type, and their advan-
tages and disadvantages. Table 1 briefly summarizes data from the
reviewed articles.
Our analysis arranges hydrogels for brain injury repair into three
principal categories: (1) potentially applicable for brain injury therapy
Table 1
Summary of the hydrogel types and their applicability for brain tissue regeneration.
Hydrogel Origin Immuno-genicity Bio-degradability Porosity Bio-compatibility Neuronal differentiation Neurite outgrowth
HA Natural − ++ + + + +
Collagen type I Natural ± + + + + +
Alginate Natural − − − + + +
Chitosan Natural − + + + + −
(HA)methyl-cellulose Natural − + + + + +
Matrigel Natural + + + ± + +
Fibrin Natural ± + + + + +
Gellan gum Natural ± + + ± − ±
Self-assembling peptides Semi-natural ± + + + + +
PEG Synthetic − − ± + − +
MA/MAA Synthetic + − + + + +
Abbreviations: +: suitable; −: unsuitable; ±: need further studies. HA- hyaluronic acid; PEG – poly(ethyleneglycol); MA – methacrylate; MAA – methacrylamide.
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(HA-, collagen type I-, alginate-, chitosan-, methylcellulose-, fibrin-, and
self-assembling peptide-based hydrogels), (2) hydrogels that do not
meet basic requirements for human brain injury therapy (potentially
carcinogenic Matrigel and stiff and non-degradable MA- and MAA-
based synthetic materials), and (3) hydrogels that hold promise for
further investigations (gellan gum-, PEG-based, and other multi-
component systems).
It is clear that the ‘plain’ hydrogel matrices are rarely sufficient for
brain tissue engineering. Even modified hydrogels impregnated with
cells are not deprived of significant drawbacks like insufficiency of
neurite guidance, poor integration, and probability of side effects and
other clinical complications such as formation of the epileptic focus.
Thus, the future design of hydrogels must target the production of com-
plex hybrid systems involving the neuroprosthetic [178,179] and
bioprinting [6] technologies, exploring other biocompatible and natu-
rally occurring polymers and possibly developing new in vitro and
ex vivomodels of neuroregeneration.
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